Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000948337 | SCV001094540 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000948337 | SCV001746945 | likely benign | not provided | 2025-02-01 | criteria provided, single submitter | clinical testing | KMT2C: BP4, BP7, BS2 |
Breakthrough Genomics, |
RCV000948337 | SCV005219877 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724193 | SCV001955805 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000948337 | SCV001966963 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004533631 | SCV004743171 | benign | KMT2C-related disorder | 2022-01-19 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |